Global Varicella Attenuated Live Vaccine Competitive Landscape Professional Research Report 2024

Global Varicella Attenuated Live Vaccine Competitive Landscape Professional Research Report 2024



Research Summary

The Varicella Attenuated Live Vaccine, commonly known as the Varicella vaccine or chickenpox vaccine, is a preventive immunization designed to protect against the varicella-zoster virus, which causes chickenpox. This vaccine is composed of weakened or attenuated live viruses that stimulate the immune system to produce an immune response without causing the disease itself. Administered through a series of doses, the Varicella vaccine is highly effective in preventing chickenpox and reducing the severity of the illness in case of exposure. It is a crucial component of routine childhood immunization schedules in many countries, contributing to the control and prevention of chickenpox outbreaks and associated complications. Additionally, the vaccine has been instrumental in reducing the incidence of herpes zoster (shingles), which can occur later in life as a reactivation of the varicella-zoster virus.

According to DIResearch's in-depth investigation and research, the global Varicella Attenuated Live Vaccine market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Varicella Attenuated Live Vaccine include Merck, BCHT, Shanghai Institute, GSK, Keygen, Green Cross, Biken, Shanghai Rongsheng Biotech, Changchun Changsheng Life Sciences Limited etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Varicella Attenuated Live Vaccine. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Varicella Attenuated Live Vaccine market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Varicella Attenuated Live Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Varicella Attenuated Live Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Varicella Attenuated Live Vaccine Include:

Merck

BCHT

Shanghai Institute

GSK

Keygen

Green Cross

Biken

Shanghai Rongsheng Biotech

Changchun Changsheng Life Sciences Limited

Varicella Attenuated Live Vaccine Product Segment Include:

Monovalent Vaccine

Combination Vaccine

Varicella Attenuated Live Vaccine Product Application Include:

Kids Injection

Adults Injection

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Varicella Attenuated Live Vaccine Industry PESTEL Analysis

Chapter 3: Global Varicella Attenuated Live Vaccine Industry Porter’s Five Forces Analysis

Chapter 4: Global Varicella Attenuated Live Vaccine Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Varicella Attenuated Live Vaccine Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Varicella Attenuated Live Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Varicella Attenuated Live Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Varicella Attenuated Live Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Varicella Attenuated Live Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Varicella Attenuated Live Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Varicella Attenuated Live Vaccine Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Varicella Attenuated Live Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources


1 Varicella Attenuated Live Vaccine Market Overview
1.1 Product Definition and Statistical Scope
1.2 Varicella Attenuated Live Vaccine Product by Type
1.2.1 Global Varicella Attenuated Live Vaccine Market Size by Type, 2023 VS 2024 VS 2030
1.2.2 Monovalent Vaccine
1.2.3 Combination Vaccine
1.3 Varicella Attenuated Live Vaccine Product by Application
1.3.1 Global Varicella Attenuated Live Vaccine Market Size by Application, 2023 VS 2024 VS 2030
1.3.2 Kids Injection
1.3.3 Adults Injection
1.4 Global Varicella Attenuated Live Vaccine Market Revenue and Sales Analysis
1.4.1 Global Varicella Attenuated Live Vaccine Market Size Analysis (2019-2030)
1.4.2 Global Varicella Attenuated Live Vaccine Market Sales Analysis (2019-2030)
1.4.3 Global Varicella Attenuated Live Vaccine Market Sales Price Trend Analysis (2019-2030)
1.5 Varicella Attenuated Live Vaccine Market Development Status and Trends
1.5.1 Varicella Attenuated Live Vaccine Industry Development Status Analysis
1.5.2 Varicella Attenuated Live Vaccine Industry Development Trends Analysis
2 Varicella Attenuated Live Vaccine Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Varicella Attenuated Live Vaccine Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Varicella Attenuated Live Vaccine Market Analysis by Regions
4.1 Varicella Attenuated Live Vaccine Overall Market: 2023 VS 2024 VS 2030
4.2 Global Varicella Attenuated Live Vaccine Revenue and Forecast Analysis (2019-2030)
4.2.1 Global Varicella Attenuated Live Vaccine Revenue and Market Share by Region (2019-2024)
4.2.2 Global Varicella Attenuated Live Vaccine Revenue Forecast by Region (2025-2030)
4.3 Global Varicella Attenuated Live Vaccine Sales and Forecast Analysis (2019-2030)
4.3.1 Global Varicella Attenuated Live Vaccine Sales and Market Share by Region (2019-2024)
4.3.2 Global Varicella Attenuated Live Vaccine Sales Forecast by Region (2025-2030)
4.4 Global Varicella Attenuated Live Vaccine Sales Price Trend Analysis (2019-2030)
5 Global Varicella Attenuated Live Vaccine Market Size by Type and Application
5.1 Global Varicella Attenuated Live Vaccine Market Size by Type
5.1.1 Global Varicella Attenuated Live Vaccine Revenue and Forecast Analysis by Type (2019-2030)
5.1.2 Global Varicella Attenuated Live Vaccine Sales and Forecast Analysis by Type (2019-2030)
5.2 Global Varicella Attenuated Live Vaccine Market Size by Application
5.2.1 Global Varicella Attenuated Live Vaccine Revenue and Forecast Analysis by Application (2019-2030)
5.2.2 Global Varicella Attenuated Live Vaccine Sales and Forecast Analysis by Application (2019-2030)
6 North America
6.1 North America Varicella Attenuated Live Vaccine Market Size and Growth Rate Analysis (2019-2030)
6.2 North America Key Manufacturers Analysis
6.3 North America Varicella Attenuated Live Vaccine Market Size by Type
6.3.1 North America Varicella Attenuated Live Vaccine Sales by Type (2019-2030)
6.3.2 North America Varicella Attenuated Live Vaccine Revenue by Type (2019-2030)
6.4 North America Varicella Attenuated Live Vaccine Market Size by Application
6.4.1 North America Varicella Attenuated Live Vaccine Sales by Application (2019-2030)
6.4.2 North America Varicella Attenuated Live Vaccine Revenue by Application (2019-2030)
6.5 North America Varicella Attenuated Live Vaccine Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Varicella Attenuated Live Vaccine Market Size and Growth Rate Analysis (2019-2030)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Varicella Attenuated Live Vaccine Market Size by Type
7.3.1 Europe Varicella Attenuated Live Vaccine Sales by Type (2019-2030)
7.3.2 Europe Varicella Attenuated Live Vaccine Revenue by Type (2019-2030)
7.4 Europe Varicella Attenuated Live Vaccine Market Size by Application
7.4.1 Europe Varicella Attenuated Live Vaccine Sales by Application (2019-2030)
7.4.2  Europe Varicella Attenuated Live Vaccine Revenue by Application (2019-2030)
7.5 Europe Varicella Attenuated Live Vaccine Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Varicella Attenuated Live Vaccine Market Size and Growth Rate Analysis (2019-2030)
8.2 China Key Manufacturers Analysis
8.3 China Varicella Attenuated Live Vaccine Market Size by Type
8.3.1 China Varicella Attenuated Live Vaccine Sales by Type (2019-2030)
8.3.2 China Varicella Attenuated Live Vaccine Revenue by Type (2019-2030)
8.4 China Varicella Attenuated Live Vaccine Market Size by Application
8.4.1 China Varicella Attenuated Live Vaccine Sales by Application (2019-2030)
8.4.2 China Varicella Attenuated Live Vaccine Revenue by Application (2019-2030)
9 APAC (excl. China)
9.1 APAC (excl. China) Varicella Attenuated Live Vaccine Market Size and Growth Rate Analysis (2019-2030)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Varicella Attenuated Live Vaccine Market Size by Type
9.3.1 APAC (excl. China) Varicella Attenuated Live Vaccine Sales by Type (2019-2030)
9.3.2 APAC (excl. China) Varicella Attenuated Live Vaccine Revenue by Type (2019-2030)
9.4 APAC (excl. China) Varicella Attenuated Live Vaccine Market Size by Application
9.4.1 APAC (excl. China) Varicella Attenuated Live Vaccine Sales by Application (2019-2030)
9.4.2 APAC (excl. China) Varicella Attenuated Live Vaccine Revenue by Application (2019-2030)
9.5 APAC (excl. China) Varicella Attenuated Live Vaccine Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Indonesia
9.5.6 Vietnam
9.5.7 Malaysia
9.5.8 Thailand
10 Latin America
10.1 Latin America Varicella Attenuated Live Vaccine Market Size and Growth Rate Analysis (2019-2030)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Varicella Attenuated Live Vaccine Market Size by Type
10.3.1 Latin America Varicella Attenuated Live Vaccine Sales by Type (2019-2030)
10.3.2 Latin America Varicella Attenuated Live Vaccine Revenue by Type (2019-2030)
10.4 Latin America Varicella Attenuated Live Vaccine Market Size by Application
10.4.1 Latin America Varicella Attenuated Live Vaccine Sales by Application (2019-2030)
10.4.2 Latin America Varicella Attenuated Live Vaccine Revenue by Application (2019-2030)
10.5 Latin America Varicella Attenuated Live Vaccine Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Varicella Attenuated Live Vaccine Market Size and Growth Rate Analysis (2019-2030)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Varicella Attenuated Live Vaccine Market Size by Type
11.3.1 Middle East & Africa Varicella Attenuated Live Vaccine Sales by Type (2019-2030)
11.3.2 Middle East & Africa Varicella Attenuated Live Vaccine Revenue by Type (2019-2030)
11.4 Middle East & Africa Varicella Attenuated Live Vaccine Market Size by Application
11.4.1 Middle East & Africa Varicella Attenuated Live Vaccine Sales by Application (2019-2030)
11.4.2 Middle East & Africa Varicella Attenuated Live Vaccine Revenue by Application (2019-2030)
11.5 Middle East & Africa Varicella Attenuated Live Vaccine Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global Varicella Attenuated Live Vaccine Market Sales, Revenue and Price by Key Manufacturers (2020-2024)
12.1.1 Global Varicella Attenuated Live Vaccine Market Sales by Key Manufacturers (2020-2024)
12.1.2 Global Varicella Attenuated Live Vaccine Market Revenue by Key Manufacturers (2020-2024)
12.1.3 Global Varicella Attenuated Live Vaccine Average Sales Price by Manufacturers (2020-2024)
12.2 Varicella Attenuated Live Vaccine Competitive Landscape Analysis and Market Dynamic
12.2.1 Varicella Attenuated Live Vaccine Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Merck
13.1.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Merck Varicella Attenuated Live Vaccine Product Portfolio
13.1.3 Merck Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.2 BCHT
13.2.1 BCHT Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 BCHT Varicella Attenuated Live Vaccine Product Portfolio
13.2.3 BCHT Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.3 Shanghai Institute
13.3.1 Shanghai Institute Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Shanghai Institute Varicella Attenuated Live Vaccine Product Portfolio
13.3.3 Shanghai Institute Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.4 GSK
13.4.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 GSK Varicella Attenuated Live Vaccine Product Portfolio
13.4.3 GSK Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.5 Keygen
13.5.1 Keygen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Keygen Varicella Attenuated Live Vaccine Product Portfolio
13.5.3 Keygen Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.6 Green Cross
13.6.1 Green Cross Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Green Cross Varicella Attenuated Live Vaccine Product Portfolio
13.6.3 Green Cross Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.7 Biken
13.7.1 Biken Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.7.2 Biken Varicella Attenuated Live Vaccine Product Portfolio
13.7.3 Biken Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.8 Shanghai Rongsheng Biotech
13.8.1 Shanghai Rongsheng Biotech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.8.2 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Product Portfolio
13.8.3 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
13.9 Changchun Changsheng Life Sciences Limited
13.9.1 Changchun Changsheng Life Sciences Limited Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.9.2 Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Product Portfolio
13.9.3 Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)
14 Industry Chain Analysis
14.1 Varicella Attenuated Live Vaccine Industry Chain Analysis
14.2 Varicella Attenuated Live Vaccine Industry Upstream Supply Analysis
14.2.1 Upstream Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Varicella Attenuated Live Vaccine Typical Downstream Customers
14.4 Varicella Attenuated Live Vaccine Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings